Scotland · NHS Scotland MSAN
Tocilizumab (RoActemra®) 162mg/0.9ml solution for injection pre-filled
MSAN(2021)34 · Level 3 · issued 09 Nov 2021
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| pens are in limited supply until January 2022 due to increased global demand on the active | Limited supply | January 2022 |
| Sanofi and the initiatingBoard will need to ensure that appropriate training is available, either on | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2021:34
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
4ad21ba1bd5162aa7c42120ffbe669c43d3ea9262407f6881c2c1c2165002badsha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2021-34.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.